BICYCLE THERAPEUTICS PLC-ADR (BCYC) Stock Income Statement
NASDAQ:BCYC - Nasdaq - US0887861088 - ADR - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 25.72M | 35.27M | 26.98M | 14.46M | 11.70M | |||
| Operating Expenses | 273.09M | 244.43M | 216.33M | 130.56M | 77.68M | |||
| Research and Development | 197.16M | 172.97M | 156.50M | 81.61M | 44.88M | |||
| Selling, General, and Administrative Expenses | 75.93M | 71.46M | 59.83M | 48.95M | 32.79M | |||
| Operating Income | -247.37M | -209.15M | -189.35M | -116.09M | -65.98M | |||
| Interest Income/Expense | 35.13M | 31.84M | 10.14M | 1.85M | -2.50M | |||
| Other Income/Expense | N/A | N/A | N/A | N/A | N/A | |||
| Non Recurring Items | N/A | 3.52M | N/A | N/A | N/A | |||
| Income Before Taxes | -208.72M | -173.80M | -179.21M | -114.24M | -68.48M | |||
| Income Tax | -5.50M | -4.76M | 1.46M | -1.52M | -1.66M | |||
| Net Income | -203.22M | -169.03M | -180.66M | -112.72M | -66.82M | |||
| EBITDA | -240.22M | -201.98M | -182.81M | -112.40M | -64.57M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -3.13 | -2.90 | -5.07 | -3.80 | -2.67 | |||
| Non GAAP EPS | -3.21 | -2.95 | -5.13 | -3.80 | -2.69 | |||
| Statistics | ||||||||
| Profit Margin | -790.07% | -479.18% | -669.72% | -779.53% | -571.11% | |||
| Operating Profit Margin | -961.71% | -592.92% | -701.93% | -802.84% | -563.93% | |||
All data in USD